These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction. Livnat T, Weinberger Y, Fernández JA, Bashir A, Ben-David G, Palevski D, Levy-Mendelovich S, Kenet G, Budnik I, Nisgav Y, Griffin JH, Weinberger D. Biomolecules; 2021 Feb 26; 11(3):. PubMed ID: 33652861 [Abstract] [Full Text] [Related]
4. 3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina. Weinberger Y, Budnik I, Nisgav Y, Palevski D, Ben-David G, Fernández JA, Margalit SN, Levy-Mendelovich S, Kenet G, Weinberger D, Griffin JH, Livnat T. Int J Mol Sci; 2023 Jun 26; 24(13):. PubMed ID: 37445820 [Abstract] [Full Text] [Related]
5. Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization. Meyer JH, Larsen PP, Strack C, Harmening WM, Krohne TU, Holz FG, Schmitz-Valckenberg S. Exp Eye Res; 2019 Jul 26; 184():162-171. PubMed ID: 31002822 [Abstract] [Full Text] [Related]
8. Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization. Semkova I, Fauser S, Lappas A, Smyth N, Kociok N, Kirchhof B, Paulsson M, Poulaki V, Joussen AM. FASEB J; 2006 Aug 26; 20(10):1689-91. PubMed ID: 16807368 [Abstract] [Full Text] [Related]
9. Activation of the Small GTPase Rap1 Inhibits Choroidal Neovascularization by Regulating Cell Junctions and ROS Generation in Rats. Li J, Zhang R, Wang C, Wang X, Xu M, Ma J, Shang Q. Curr Eye Res; 2018 Jul 26; 43(7):934-940. PubMed ID: 29601231 [Abstract] [Full Text] [Related]
10. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression. Lavine JA, Farnoodian M, Wang S, Darjatmoko SR, Wright LS, Gamm DM, Ip MS, Sorenson CM, Sheibani N. Invest Ophthalmol Vis Sci; 2017 Jan 01; 58(1):299-308. PubMed ID: 28114591 [Abstract] [Full Text] [Related]
11. Targeting of junctional adhesion molecule-C inhibits experimental choroidal neovascularization. Hou X, Hu D, Wang YS, Tang ZS, Zhang F, Chavakis T, Li Y, Li X. Invest Ophthalmol Vis Sci; 2012 Mar 01; 53(3):1584-91. PubMed ID: 22323465 [Abstract] [Full Text] [Related]
12. A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration. Narendran S, Pereira F, Yerramothu P, Apicella I, Wang SB, Varshney A, Baker KL, Marion KM, Ambati M, Ambati VL, Ambati K, Sadda SR, Gelfand BD, Ambati J. Invest Ophthalmol Vis Sci; 2020 Aug 03; 61(10):4. PubMed ID: 32749462 [Abstract] [Full Text] [Related]
16. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization. Tolentino MJ, Husain D, Theodosiadis P, Gragoudas ES, Connolly E, Kahn J, Cleland J, Adamis AP, Cuthbertson A, Miller JW. Arch Ophthalmol; 2000 Jan 03; 118(1):78-84. PubMed ID: 10636419 [Abstract] [Full Text] [Related]
17. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice. Roh YJ, Jee D, Rho CR, Cho WK, Kang S. Clin Exp Ophthalmol; 2016 Jan 03; 44(1):43-51. PubMed ID: 26221970 [Abstract] [Full Text] [Related]